Nanoparticle Therapeutics
portes grátis
Nanoparticle Therapeutics
Production Technologies, Types of Nanoparticles, and Regulatory Aspects
Kesharwani, Prashant; Singh, Kamalinder K.
Elsevier Science Publishing Co Inc
11/2021
672
Mole
Inglês
9780128207574
15 a 20 dias
450
Descrição não disponível.
Part 1: Synthesis and characterization of NP for drug delivery1. Nanoparticles: Recent state-of-art and prospective challenges2. Fabrication, process technologies and challenges in development of nanoparticles3. In vitro and physicochemical characterization of nanoparticles4. Surface-engineering of nanoparticles for imparting multifuntionality5. Biofate and cellular interactions of nanoparticles6. Pharmacokinetics and in vivo evaluation of nanoparticles
Part 2: Application of Nanoparticles in Drug Delivery7. Biodegradable polymeric nanoparticles for sustained drug delivery8. Lipidic nanoparticles with improved biopharmaceutical attributes9. Protein-based nanoparticles for drug delivery10. Gold and silver nanoparticles for drug delivery11. Mesoporous silica and silicates nanoparticles for drug delivery12. Targeted nanosuspensions for improved therapeutics13. SPIONS as therapeutic and diagnostic agents14. Bio-inspired nanoparticles/exosomes vesicles as drug delivery vehicles
Part 3: Environmental and Regulatory Aspects14. Regulatory pathways and federal perspectives on nanoparticles15. Environmental hazards associated with nanoparticles16. Biological toxicity of nanoparticles
Part 2: Application of Nanoparticles in Drug Delivery7. Biodegradable polymeric nanoparticles for sustained drug delivery8. Lipidic nanoparticles with improved biopharmaceutical attributes9. Protein-based nanoparticles for drug delivery10. Gold and silver nanoparticles for drug delivery11. Mesoporous silica and silicates nanoparticles for drug delivery12. Targeted nanosuspensions for improved therapeutics13. SPIONS as therapeutic and diagnostic agents14. Bio-inspired nanoparticles/exosomes vesicles as drug delivery vehicles
Part 3: Environmental and Regulatory Aspects14. Regulatory pathways and federal perspectives on nanoparticles15. Environmental hazards associated with nanoparticles16. Biological toxicity of nanoparticles
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Fabrication of nanoparticles; surface engineered; environmental toxicity; process technologies
Part 1: Synthesis and characterization of NP for drug delivery1. Nanoparticles: Recent state-of-art and prospective challenges2. Fabrication, process technologies and challenges in development of nanoparticles3. In vitro and physicochemical characterization of nanoparticles4. Surface-engineering of nanoparticles for imparting multifuntionality5. Biofate and cellular interactions of nanoparticles6. Pharmacokinetics and in vivo evaluation of nanoparticles
Part 2: Application of Nanoparticles in Drug Delivery7. Biodegradable polymeric nanoparticles for sustained drug delivery8. Lipidic nanoparticles with improved biopharmaceutical attributes9. Protein-based nanoparticles for drug delivery10. Gold and silver nanoparticles for drug delivery11. Mesoporous silica and silicates nanoparticles for drug delivery12. Targeted nanosuspensions for improved therapeutics13. SPIONS as therapeutic and diagnostic agents14. Bio-inspired nanoparticles/exosomes vesicles as drug delivery vehicles
Part 3: Environmental and Regulatory Aspects14. Regulatory pathways and federal perspectives on nanoparticles15. Environmental hazards associated with nanoparticles16. Biological toxicity of nanoparticles
Part 2: Application of Nanoparticles in Drug Delivery7. Biodegradable polymeric nanoparticles for sustained drug delivery8. Lipidic nanoparticles with improved biopharmaceutical attributes9. Protein-based nanoparticles for drug delivery10. Gold and silver nanoparticles for drug delivery11. Mesoporous silica and silicates nanoparticles for drug delivery12. Targeted nanosuspensions for improved therapeutics13. SPIONS as therapeutic and diagnostic agents14. Bio-inspired nanoparticles/exosomes vesicles as drug delivery vehicles
Part 3: Environmental and Regulatory Aspects14. Regulatory pathways and federal perspectives on nanoparticles15. Environmental hazards associated with nanoparticles16. Biological toxicity of nanoparticles
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.